Beneficiaries of the project

These will include:
- 'Front line' nursing and clinical care staff in secondary care settings involved in infection control and the treatment of burn patients.

- Clinical microbiologists based in secondary care settings with responsibility for infection diagnosis.

- Infection control teams responsible for monitoring and preventing hospital acquired infections.

- Academics and other scientists seeking to understand the pathogenesis of wound infections, and undertaking translational research.

There is also significant potential to adapt and exploit the novel technology as a platform technology for critical colonisation detection (infection) in other acute and chronic wounds.

Development timeline

2018 - 2019: GMP Manufacture and upscaling

2020 - 2021: Regulatory and ethical compliance, first human trial

Funded by                                                                   


Development of an infection diagnosing wound dressing

Infected with Staphylococcus aureus or  Pseudomonas aeruginosa.


Project Aims:

The project team aims to create a wound dressing that provides an early indication of infection (illustrated in the figures below) at point of care (PoC). This would significantly enhance clinical decision-making - with the capability to rapidly distinguish the bacterial Clinical Colonisation Threshold (TREAT) from sub-clinical colonisation (DON'T TREAT).

Not infected

Dressing response to Staphylococcus aureus toxins